← SynDRA
RG-7603
SynDRA canonical compound SYN0036682 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PIK3CA |
|---|
| Mechanism of action | Pim kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Pim kinase inhibitor
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
Cross-references
Synonyms
- GDC-0349
- MTORC1/2 inhibitors
- Gdc-0349
- RefChem:922128
- DTXCID6075487
- GDC0349
- RGJOJUGRHPQXGF-INIZCTEOSA-N
- UNII-579255I6O9
- MFCD22417087
- MLS006011173
- orb1685655
- SCHEMBL1831520
- SCHEMBL29373340
- GLXC-90270
- EX-A2248
- BDBM50428123
- NSC771532
- NSC780878
- NSC800987
- RG7603
- s8040
- AKOS027420911
- CCG-264711
- CS-0700
- NSC-771532
- NSC-780878
- NSC-800987
- NCGC00346465-04
- AC-31525
- HY-15248
- MS-28232
- SMR004702942
- G1310
- NS00073071
- SW220121-1
- T6510
- F84826
- BRD-K43187018-001-02-5
Look up RG-7603 in the interactive SynDRA portal →